347868 <common-name>N-[4-[[5-[1-(3-chlorophenyl)-5-[[4-(dimethylamino)phenyl]diazenyl]-4-methoxypyrazol-3-yl]-1,3,4-thiadiazol-2-yl]sulfamoyl]phenyl]acetamide</common-name> <description>N-[4-[[5-[1-(3-chlorophenyl)-5-[[4-(dimethylamino)phenyl]diazenyl]-4-methoxypyrazol-3-yl]-1,3,4-thiadiazol-2-yl]sulfamoyl]phenyl]acetamide has the chemical formula C28H26ClN9O4S2. With an average molecular weight of 652.10 g/mol, N-[4-[[5-[1-(3-chlorophenyl)-5-[[4-(dimethylamino)phenyl]diazenyl]-4-methoxypyrazol-3-yl]-1,3,4-thiadiazol-2-yl]sulfamoyl]phenyl]acetamide is a heavy molecule.</description> <cas>172701-61-0</cas> <pubchem-id>3075158</pubchem-id> <chemical-formula>C28H26ClN9O4S2</chemical-formula> <weight>652.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T11:42:34Z</created-at> <updated-at type="dateTime">2026-08-31T11:42:34Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=NN=C(S2)C3=NN(C(=C3OC)N=NC4=CC=C(C=C4)N(C)C)C5=CC(=CC=C5)Cl</moldb-smiles> <moldb-formula>C28H26ClN9O4S2</moldb-formula> <moldb-inchi>InChI=1S/C28H26ClN9O4S2/c1-17(39)30-19-10-14-23(15-11-19)44(40,41)36-28-34-33-27(43-28)24-25(42-4)26(38(35-24)22-7-5-6-18(29)16-22)32-31-20-8-12-21(13-9-20)37(2)3/h5-16H,1-4H3,(H,30,39)(H,34,36)</moldb-inchi> <moldb-inchikey>FAXXSJLSCXXYFA-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">651.1237704</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM343761</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[4-[[5-[1-(3-chlorophenyl)-5-[[4-(dimethylamino)phenyl]diazenyl]-4-methoxypyrazol-3-yl]-1,3,4-thiadiazol-2-yl]sulfamoyl]phenyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Pyrazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0298204</sync-id> <structure-inchikey>FAXXSJLSCXXYFA-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>80000000000000000000000000002000020000024000001002000800000040000000400000000011044000200000020400000000000000000000800000002000000200000004000000080400000000000200000100001000010040040000000000200000100000000504000001050000000000011000000800000000000004000010040c000040480800000000000008018000000000000000000000000020000000000000000000000000018000010000000000000000008000000000000008000000000010001000000000000040000009000080000000000020000000000000000804000000a000040000000000400020000080000000000000090000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAsAAAAMAAAAIABBgBgAAAAAQMGACgAAAAD BAgAKAAAAAMCBwBoAAAAAwIBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEG QCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDARAAIAAAAAYIACgAAAADAggAKAAA AAMCBwBoAAAAAwIBBkAoAAAAAwQHQCgAAAADAwdAKAAAAAMDBkAoAAAAAwQQ QCgAAAADAgZAKAAAAAMEB0AoAAAAAwMHQCgAAAADAwZAKAAAAAMEBkAoAAAA AwQIACgAAAADAgYAYAAAAAEDBwAoAAAAAwMHACgAAAADAwZAKAAAAAMEBkBo AAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEHACgA AAADAwYAYAAAAAEDBgBgAAAAAQMGQCgAAAADBAZAaAAAAAMDAQZAKAAAAAME BkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBEQAgAAAAAQsAAQABAigCAQMg AwQgBAVoDAUGaAwGB2gMBwhoDAgJaAwHCgAKCwgCCgwIAgoNAA0OIA4PaAwP EGgMEBFoDBESaAwREyATFGgMFBVoDBUWaAwWF2gMFxggGBkAFhogGhsoAhsc IBwdaAwdHmgMHh9oDB8gaAwgIWgMHyIgIiMAIiQAFSUgJSZoDCYnaAwnKGgM KCloDCkqaAwnKwAJBGgMEg5oDBcTaAwhHGgMKiVoDEIFAAAABgQJCAcGBQUP DhIREAUUExcWFQYdHh8gIRwGJicoKSolFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:25Z</structure-indexed-at> </compound>